Dr. Wassil Nowicky — Dipl. Ing., Dr. techn., DDDr. h. c., Director of “Nowicky Pharma” and President of the Ukrainian Anti-Cancer Institute (Vienna, Austria). Has finished his study at the Radiotechnical Faculty of the Technical University of Lviv (Ukraine) with the end of 1955 with graduation to “Diplomingeniueur” in 1960 which title was nostrificated in Austria in 1975. Dr. Wassil Nowicky became the very first scientist in the development of the anticancer protonic therapy and is the inventor of the preparation against cancer with a selective effect on basis of celandine alkaloids “NSC-631570”. He used the factor that cancer cells are more negative charged than normal cells and invented the Celandine alkaloid with a positive charge thanks to which it accumulates in cancer cells very fast. Author of over 300 scientific articles dedicated to cancer research. Dr. Wassil Nowicky is a real member of the New York Academy of Sciences, member of the European Union for applied immunology and of the American Association for scientific progress, honorary doctor of the Janka Kupala University in Hrodno, doctor “honoris causa” of the Open international university on complex medicine in Colombo, honorary member of the Austrian Society of a name od Albert Schweizer. He has received the award for merits of National guild of pharmasists of America. the award of Austrian Society of sanitary, hygiene and public health services and others.
Oncology, Gastroenterology, pancreatology,
Daniela Capdepon MD, graduate of the University F. Medical Barceló in 2001 with honors and highest academic average. Make residency in Internal Medicine at the Municipal hospital and COBA oriented Graduate Clinical Oncology from 2002 to 2004. Then I began to study the specialty of Clinical Oncology at the University of Salvador, trained in gastric tumors in Udaondo Hospital, Hospital Marie Curie Cancer Center and Henry Moore at where we learned to prepare and deliver chemotherapies and concurrences to form the pallium Center for palliative treatment of pain. Graduated in the specialty of clinical oncologist and palliative medicine subspecialty in Pain in 2006 of Salvador University, Buenos Aires. Oncologist at Work as outpatient and outpatient chemotherapy treatments made in Municipal Hospital and Italian Society of Zarate and Campana. Fellow in Fundaleu as subinvestigadora in Oncohematology and where do my training in liquid tumors, LLC, ALL MM, NHL LH. During 2006-2007. In 2008 I built my own Cancer Center, of which I am the owner and medical director, is Campana Cancer Center, where cancer care is done in outpatient chemotherapy treatments and pain and palliative treatments. Together with a specialized team that works with me. We also conduct Cancer Center, clinical research protocols in various tumors. Starting a new labor stage in the province of Entre Rios as oncologist responsible for the service in Peru Galarza General Hospital. And St. Joseph Medical.
Tumors, Cancer, Oncology and Oncohematology
International speaker on Biotechnology (mRNA) and its clinical applications with "No Option" patients. Served in various capacities in private and public practices, as hospital staff physician and as an emergency health services coordinator for a variety of private and public institutions throughout Mexico. Managed a Blood Bank from 2009-2012. MD degrees at Westhill University and the National Autonomous University of Mexico and am a qualified Physician Surgeon. Diplomate in Aesthetic Medicine from the Autonomous University of Guadalajara, and I am an Advanced Fellow with the American Board of Anti-Ageing and Regenerative Medicine, a Visiting Scholar in Dermatology, at the University of North Carolina, Chapel Hill. Fellow in Stem Cell Medicine with both the American Academy of Anti-Ageing Medicine and University of South Florida.
Medical Doctor & business executive focused on Regenerative Medicine, Biotechnology, Medical Education & commercialization.
Dr.Achour Radhouane is an associate professor at the faculty of medicine of Tunis-Tunisia; He has published many basic and clinical articles in relation to gynecology and obstetrics; His research interests include Rare Diseases in gynecology and prenatal diagnosis. He serves as associate professor, Emergency Department of Gynecology and Obstetrics in maternity and neonatology centre Tunis Tunisia. He also serves as the member of the editorial team for Asian Pacific Journal of Reproduction, the Global Journal of Rare Diseases, Journal of Neonatal Biology, Current pediatric research, Obstetrics and Gynecology: Open access, Pediatrics and Health Research and Member of the Science Advisory Board.
Prof. Danny Gohel completed his Clinical Chemistry degree in USA and returned to Hong Kong for PhD studiesat the University of Hong Kong. He is currently working as a Professor of Biomedical Sciences and Associate Vice-President (Academic Development) at the Tung Wah College, Hong Kong.His research interests are in the areas of Bladder cancer pathobiology,Glycosaminoglycans,Nano-magnetic particles; Rare cell isolation,Renal stone disease, Heavy metal detection; Traditional Chinese medicine in Therapeutic evidences.
Bladder Cancer; Chinese Medicine; Therapeutics Glycosaminoglycan; Renal Stone Disease; General Biochemistry and Immunology Research
He has worked as associate professor in the Department of Psychiatry and a senior research scientist in the Scientific Laboratory (Alcohol and Drug-Related Problems Research Group) at the Grodno State Medical University (Belarus). He has published about 1000 papers in English and Russian language peer-reviewed journals and 30 monographs. He is a founding member of the International Society of Addiction Medicine (ISAM), presiding member of the International Academy of Sobriety (IAS), national representative for Belarus of World Suicidology Net and is an active member of National Association of Psychiatrists.
Epidemiology of suicides and different aspects of alcohol and drug-related problems
Prof. Dr. C.P Abdolrasoul Aleezaadeh completed his Post Doctorate in (Psychology) at Approach of Applied Clinical Cognitive Neuropsychology from the USA. Prof. Dr. Aleezaadeh Completed his Ph.D. Degrees in Psychology at the USA. He completed his Master's Degree in Clinical Psychology at I. R. of the IRAN and Bachelor's Degree in General Psychology at I. R. of the IRAN. He is Full Expert International Faculty Professorship Member in the Brooklyn Central University, the USA, Associate Expert International Faculty Professorship Member in the University of Pacific Albion, the USA and, Associate Expert International Faculty Professorship Member in the Green Lake (GreenLake) University, the USA. Now he is working as an Assistant Professor at P.N.U and, U.A.S.T Universities; I.R. of IRAN.
Cognitive Sciences, Cognitive Neurosciences, Neuroimaging, Applied Clinical Neuropsychology, Brain ( Cranial ) Imaging, Traditional Medicine, Homeopathic Medicine and, Combination of Medical and, Psychological trends for eradicating illnesses / sicknesses
Oncogenesis, Cancer Metastasis, Cancer Stem Cells, Tumor Cell Biology,
Mr. De la Parra is an entrepreneur focused on Information Technology, Education and Health. He is creative and results-driven and has 16+ years of Digital Strategy experience in architecture and implementation. Mr. De la Parra is the COO and Co-founding Partner at The Solomon Brokerage Firm. He currently leads as CEO at Mass Media Division & De la Parra Mobile Solutions, while also being the President of PetroM Renewable, VP of Operations & Strategy at PetroM Logistics, both divisions of PetroM Corp. Former COO & Co-founder at RegenerAge® Clinic & RegenerAge® Beauty & a member of the Board of Advisors. Former CEO & Founder at Astrum Salud Móvil and its Telemedicine service Astrum Móvil, former Digital Strategy Director & Co-founder at Dr. Jois®, BiorganicAging®, What Skin Needs™/WSN International Pty. Ltd. He also served as a member of the Board of Advisors and is former CMO at ReAnima Advanced Biosciences and former Digital Media Director at Bioquark, Inc. Within the academic and educational fields, Mr. De la Parra acted as the Executive Vice President: Executive Chairman of the WAMS Mobile Health Division, WAMS Chief Coordinating Officer, a member of the WAMS Executive Council (WAMS Executive Board), a member of the WAMS Education & Training Board (ETB), a member of the WAMS Editorial Board, an Honorary Member of the Academy Faculty FWAMS, an Honorary Fellow of the Academy & is also a Senior Partner at WAMS, The World Academy of Medical Sciences. He is also an Advisory Board member, functioned as the Chief Operating Officer and is a Co-founding Partner at The Reprogramming Medicine Association. Mr. De la Parra is also a member of the National Introducing Brokers Association and a part of the National Biofuel Board, (Alliance Program), also being the founder and former Board of Directors member of Astrum Fundación, an Advisory Board member of the Lifeboat Foundation, an Advisory Board member of the Future Worlds Center - Cyprus Neuroscience & Technology Institute (Senior TV Program), a Federated member of the International Longevity Alliance, and volunteered as Digital Strategy adviser at the Major Mouse Testing Program. He is also a member of the Web Committee at the Life Extension Advocacy Foundation / Lifespan.io and has volunteered with SENS Research Foundation for the OncoSENS Program in Digital Strategy. Alejandro De la Parra Solomon is on Google+, Facebook, and on LinkedIn.
Neuroscience, Regenerative Medicine, Continued Medical Education, Information & Communications Technology, Biotechnology, Social Development, Energy Technologies
Gerald C. Hsu received an honorable PhD in mathematics and majored in engineering at MIT. He attended different universities over 17 years and studied seven academic disciplines. He has spent 20,000 hours in T2D research. First, he studied six metabolic diseases and food nutrition during 2010-2013, then conducted research during 2014-2018. His approach is “math-physics and quantitative medicine” based on mathematics, physics, engineering modeling, signal processing, computer science, big data analytics, statistics, machine learning, and AI. His main focus is on preventive medicine using prediction tools. He believes that the better the prediction, the more control you have.